非传统生物标志物对慢性肾脏病合并心血管疾病风险预测的意义  

Predictive significance of non-traditional biomarkers in chronic kidney diseases complicated cardiovascular diseases author

作　　者：李雅欣 周鑫[1] LI Ya-xin;ZHOU Xin(Department of Cardiology,Second Affiliated Hospital of Harbin Medical University,Harbin,Heilongjiang,150081,China)

机构地区：[1]哈尔滨医科大学附属第二医院心内科,黑龙江哈尔滨150081

出　　处：《心血管康复医学杂志》2021年第3期332-335,共4页Chinese Journal of Cardiovascular Rehabilitation Medicine

摘　　要：改善心血管疾病的管理有可能显著改善慢性肾脏病患者的健康和结局。目前已发现心肌肌钙蛋白、B型利钠肽、冠脉钙化与慢性肾脏病患者心血管疾病死亡风险相关,并且有助于心血管疾病风险预测。本文主要总结非传统生物标志物升高对慢性肾脏病合并心血管疾病风险预测的意义。Improving the management of cardiovascular diseases may significantly improve health and outcome of patients with chronic kidney disease(CKD).At present,cardiac troponin,B-type natriuretic peptide,coronary artery calcification have been found to be related with the risk of cardiovascular disease death in CKD patients,and they are help for the risk prediction of cardiovascular diseases.The present article mainly reviews the predictive significance of elevated non-traditional biomarkers in CKD complicated cardiovascular diseases.

关 键 词：肾病 生物学标记 心血管疾病 

分 类 号：R54[医药卫生—心血管疾病]